DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia is a research paper published in Clinical and Translational Science (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA215802
National Institutes of Health
Grant: R01CA238946
National Institutes of Health
Grant: R01CA138744
National Institutes of Health
Grant: R01CA132946
National Institutes of Health
Grant: 5R01CA132946-08
Pharmacogenomics of Ara-C in AML
National Institutes of Health
Grant: 5R01CA138744-07
Tyrosine kinase inhibitors for the treatment of childhood AML
National Institutes of Health
Grant: 5R01CA215802-04
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
National Institutes of Health
Grant: 5R01CA238946-03
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib
Comprehensive Cancer Center, City of Hope
FWCI
1.83
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals